Higher cellular A3G protein levels were associated with decreased infectivity and spread of HIV virions after <i>ex vivo</i> activation and infection of primary memory T lymphocyte... by MariaPia De Pasquale (471291)

The substitution F447L is adaptive for J4_S52-HVR1, while it decreases infectivity of parental J4 and J4_ΔHVR1 HCVcc. by Christina Holmboe Olesen (11154333)

FABP5 expression levels in brain microvessels from 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

Subjects:

Fraction of time, the overall of the studied data trends durations follow a geometric distribution with parameter <i>p</i> = 0.5, and with any <i>p</i>, both cases for a significan... by Héctor Raúl Olivares-Sánchez (13014866)

Reduced RabGEF1 expression decreases NGF-induced TrkA phosphorylation but not TrkA internalization. by See-Ying Tam (828866)

Exposure to IQ3A compounds decreases <i>HSP90</i> and <i>KRAS</i> mRNA, protein expression and <i>KRAS</i> transcription. by Hugo Brito (747224)

A decreased response to yeast odorant attractant is observed in <i>sema1a</i> knockdown animals. by Keshava Mysore (413368)

Mean weekly decrease of most abundant sequence passaged in immunosuppressed rabbits and <i>in vitro</i> culture by variable region. by Michelle J. Lin (8677371)

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”

V2 vasopressin receptor abundance. by Sophie Constantin Lütken (689916)

Subjects:

AM251 reverses TGF-β1-dependent decreases in E-cadherin expression. by Tomoyo Yoshinaga (3391553)

Inhibition of Ric-8A or Gα_i activity decreases the recruitment of PtdIns(3)P sensor. by Cedric Boularan (269965)

<i>btuE</i> expression results in decreased intracellular ROS. by Felipe A. Arenas (23050)

(R)-albuterol decreases cytokine mRNA levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

The AMPK inhibitor CC exacerbates palmitate-induced decreases in viability. by Dustin M. Lee (8207457)

CoREST1 and CoREST2, but not CoREST3 decrease during cortical neurons maturation. by Julián Esteban Sáez (760988)

CC-1⁺ immunostained cell numbers decrease by 2 days after TBI and return to control levels by 5 weeks. by Krista A. Dent (709531)

“…Panels show contralateral (Contra) and ipsilateral (Ipsi) external capsule (EC) at (A,B) 2 days (2d), (C,D) 2 weeks (2w) and (E,F) 5 weeks (5w) (G) In the external capsule numbers of CC-1⁺ oligodendrocytes were decreased by 2d after injury, remained decreased at 2 weeks and returned to normal levels by 5 weeks. …”

Levels of the antioxidant enzyme, MnSOD are decreased in the cortical and hippocampal microvessels. by Susan A. Austin (768265)

TBEV infection decrease levels of 18S and 28S rRNA but not 5S rRNA. by Martin Selinger (3195987)

NSC population and proliferation decrease drastically during the second postnatal week of DG development. by Cristina Medina-Menéndez (21800157)